ArticleTherapeutic advances in medical oncology2026

HLX07, a novel anti-EGFR antibody, for locally advanced and metastatic cutaneous squamous cell carcinoma: an open-label, multicenter, phase II trial.

Changxing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.